Evaluating the Gendolcat Score for predicting chronic pain after cesarean sections
Validation of the Gendolcat Score for the Prognosis of Chronic Postoperative Pain in Cesarean Section.
This study is testing if the Gendolcat Score can help predict the risk of chronic pain after cesarean sections for women who have this surgery.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 371 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Consorci Sanitari de Terrassa Academic / other |
| Locations | 1 site (Badalona, Barcelona) |
| Trial ID | NCT05739747 on ClinicalTrials.gov |
What this trial studies
This observational study aims to validate the Gendolcat Score, a predictive model designed to assess the risk of chronic post-surgical pain, specifically in patients who have undergone elective cesarean sections. The study will involve collecting data through questionnaires and physical examinations to determine if the Gendolcat model, previously validated for other types of surgeries, is applicable to cesarean sections. By utilizing objective pre-surgical variables, the study seeks to enhance the understanding of chronic pain risks in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are patients who have undergone elective cesarean sections and have signed the informed consent form.
Not a fit: Patients who have undergone urgent cesarean sections or have severe psychiatric conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable tool for predicting chronic pain in patients after cesarean sections, leading to better pain management strategies.
How similar studies have performed: While the Gendolcat Score has been validated for other surgical procedures, its application to cesarean sections is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who underwent elective caesarean section. * Patients who have previously signed the informed consent form. Exclusion Criteria * Urgent cesarean section. * Patients with severe psychiatric pathology. * Patients who require a different surgical approach than usual. * Patients who refuse to take part in the study and/or to sign the informed consent form. informed consent. - Patients with a high language barrier.
Where this trial is running
Badalona, Barcelona
- Hospital Universitari Germans Trias i Pujol — Badalona, Barcelona, Spain (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.